Loading...
Loading...
Browse all stories on DeepNewz
VisitWhich regulatory body will first take action on stimulant use among Wall Street bankers by December 31, 2025?
SEC • 25%
FINRA • 25%
Department of Labor • 25%
Other • 25%
Public announcements or press releases from specific regulatory bodies
Over 50 Wall Street Bankers Use Adderall and Vyvanse to Cope with 100-Hour Work Weeks at More Than a Dozen Banks
Dec 15, 2024, 02:14 AM
A recent report highlights that many Wall Street bankers rely on stimulants such as Adderall and Vyvanse to manage the demands of their high-pressure jobs. Interviews conducted with over 50 current and former investment bankers across more than a dozen firms reveal that the use of these drugs is openly discussed and prevalent in the workplace. The report emphasizes the extreme work hours, with some bankers reportedly working over 100 hours a week, leading to a reliance on increasing doses of Adderall and other substances to maintain productivity. A medical professional noted that there is a limit to human productivity, indicating the strain these long hours place on workers.
View original story
Yes • 50%
No • 50%
SEC • 25%
FDA • 25%
FINRA • 25%
Other • 25%
Goldman Sachs • 25%
JPMorgan Chase • 25%
Morgan Stanley • 25%
Other • 25%
SEC • 25%
CFTC • 25%
FTC • 25%
Other • 25%
Recordkeeping failures • 25%
Insider trading • 25%
Market manipulation • 25%
Other • 25%
Democrat • 25%
Republican • 25%
Bipartisan • 25%
Independent • 25%
Binance • 25%
Coinbase • 25%
Kraken • 25%
Other • 25%
SEC • 25%
CFTC • 25%
Federal Reserve • 25%
Other • 25%
CFTC only • 25%
SEC only • 25%
Both CFTC and SEC • 25%
Other regulatory body • 25%
FTC • 33%
CFTC • 33%
No impact • 34%
CFTC • 25%
SEC • 25%
Federal Reserve • 25%
Other • 25%
Yes • 50%
No • 50%
No • 50%
Yes • 50%
Public relations • 25%
Employee well-being • 25%
Other • 25%
Regulatory pressure • 25%